Private Advisor Group, LLC Alkermes Plc. Transaction History

Private Advisor Group, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 13, 2022	SELL	$26.4 - $30.54 $19,298 - $22,324	-731 Reduced 5.78%	11,921 $355,000
Q1 2022 May 12, 2022	BUY	$23.07 - $27.99 $1,407 - $1,707	61 Added 0.48%	12,652 $333,000
Q4 2021 Feb 10, 2022	SELL	$21.47 - $32.08 $172,532 - $257,794	-8,036 Reduced 38.96%	12,591 $293,000
Q3 2021 Oct 14, 2021	BUY	$23.37 - $32.13 $240,056 - $330,039	10,272 Added 99.2%	20,627 $636,000
Q2 2021 Aug 12, 2021	BUY	$18.78 - $25.15 $450 - $603	24 Added 0.23%	10,355 $254,000
Q1 2021 Apr 22, 2021	SELL	$18.21 - $23.2 $54 - $69	-3 Reduced 0.03%	10,331 $193,000
Q4 2020 Apr 01, 2021	SELL	$15.39 - $22.1 $138 - $198	-9 Reduced 0.09%	10,334 $207,000
Q2 2020 Aug 17, 2020	SELL	$13.31 - $19.41 $1,650 - $2,406	-124 Reduced 1.18%	10,343 $200,000
Q1 2020 May 12, 2020	SELL	$13.06 - $21.24 $1,972 - $3,207	-151 Reduced 1.42%	10,467 $151,000
Q4 2019 Feb 10, 2020	SELL	$17.29 - $21.74 $274,928 - $345,687	-15,901 Reduced 59.96%	10,618 $217,000
Q3 2019 Nov 13, 2019	BUY	$19.51 - $24.28 $255,249 - $317,655	13,083 Added 97.37%	26,519 $519,000
Q2 2019 Aug 14, 2019	BUY	$21.47 - $37.33 $288,470 - $501,565	13,436 New	13,436 $303,000

363

182M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.82B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Advisor Group, LLC with notifications on news.